UPDATE 3-Bowing to pressure, U.S. FDA approves Sarepta's Duchenne drug

Sept 19 (Reuters) - Bowing to pressure from patient
advocates, the U.S. Food and Drug Administration on Monday
approved a treatment for Duchenne muscular dystrophy even though
an outside panel of...